Qingshen Granules alleviates renal fibrosis in mice by regulating exosomes, miR-330-3p, and CREBBP expression

doi:10.12122/j.issn.1673-4254.2024.08.01

Abstract

Abstract:

Objective To explore the effects of Qingshen Granules (QSG) on adenine-induced renal fibrosis in mice and in uric acid (UA)-stimulated NRK-49F cells and its mechanism for regulating exosomes, miR-330-3p and CREBBP. Methods A mouse model of adenine-induced renal fibrosis were treated daily with QSG at 8.0 g·kg^-1·d^-1via gavage for 12 weeks. An adeno-associated virus vector was injected into the tail vein, and renal tissues of the mice were collected for analyzing exosomal marker proteins CD9, Hsp70, and TSG101 and expressions of Col-III, α‑SMA, FN, and E-cad using Western blotting and immunofluorescence and for observing pathological changes using HE and Masson staining. In the cell experiment, NRK-49F cells were stimulated with uric acid (400 μmol/L) followed by treatment with QSG-medicated serum from SD rats, and the changes in expressions of the exosomal markers and Col-III, α-SMA, FN, and E-cad were analyzed. Dual luciferase reporter assay was employed to examine the targeting relationship between miR-330-3p and CREBBP, whose expressions were detected by RT-qPCR and Western blotting in treated NRK-49F cells. Results The mouse models of adenine-induced renal fibrosis showed significantly increased levels of CD9, Hsp70, and TSG101, which were decreased by treatment with QSG. The expressions of Col-III, α‑SMA, and FN increased and E-cad decreased in the mouse models but these changes were reversed by QSG treatment. QSG treatment obviously alleviated renal fibrosis in the mouse models. Intravenous injection of adeno-associated viral vector obviously inhibited miR-330-3p, increased CREBBP levels, and reduced fibrosis in the mouse models. Dual luciferase assay confirmed CREBBP as a target of miR-330-3p, which was consistent with the results of the cell experiments. Conclusion QSG inhibits renal fibrosis in mice by regulating the exosomes, reducing miR-330-3p levels, and increasing CREBBP expression.

Key words: Qingshen Granules, exosomes, miR-330-3p, renal fibrosis

Rong DAI, Zeping CAO, Chuanjiao LIU, Yong GE, Meng CHENG, Weili WANG, Yizhen CHEN, Lei ZHANG, Yiping WANG. Qingshen Granules alleviates renal fibrosis in mice by regulating exosomes, miR-330-3p, and CREBBP expression[J]. Journal of Southern Medical University, 2024, 44(8): 1431-1440.

Figures/Tables 9

Fig.1 Qingshen Granules (QSG) inhibits renal exosome secretion in a mouse model of renal fibrosis. A, B: Western blotting and quantitative analysis of exosome marker proteins CD63, Hsp70 and TSG101 in the renal tissues of each group (n=6). *P<0.05 vs Sham group; #P<0.05 vs Model group.

Fig.2 Effect of QSG on renal fibrosis in mice. A, B: Western blotting and quantitative analysis of expressions of Col-III, α-SMA, FN and E-cad in the renal tissues in each group (n=6). C, D: Immunofluorescence analysis of Col-III, α-SMA, FN and E-cad and the quantitative data (n=6). Scale bar=50 µm. E, F: HE and Masson staining and the quantitative data (n=6). Scale bar = 50 µm. *P<0.05 vs Sham group; #P<0.05 vs Model group.

Fig.3 Inhibition of miR-330-3p expression attenuates renal fibrosis in mice. A-E: Western blotting and quantitative data of Col-III, α-SMA, FN and E-cad expressions in mouse renal tissues in each group (n=6). F, G: Immunofluorescence analysis of Col-III and FN and the quantitative data (n=6). Scale bar=50 µm. *P<0.05 vs Sham group; #P<0.05 vs Model group.

Fig.4 Inhibition of miR-330-3p increases CREBBP expression in the renal tissues of the mouse models. A, B: Western blotting and quantitative data of CREBBP in mouse kidneys (n=6). C: RT-qPCR of CREBBP mRNA (n=6). *P<0.05 vs Sham group, #P<0.05 vs Model group.

Fig.5 CREBBP is a target of miR-330-3p. A: miR-330-3p binding sites predicted in the 3'-UTR of CREBBP mRNA. B: Luciferase activity of NRK-49F cells after transfection with NC or miR-330-3p mimics and reporter vectors containing the CREBBP mutant binding sequence. #P<0.05.

Fig.6 QSG inhibits miR-330-3p expression in mouse kidney tissue and increases CREBBP levels to attenuate renal fibrosis. A: Renal miR-330-3p levels in mice in each group. B: Renal CREBBP mRNA levels in mice in each group. C, D: Western blotting of protein expression and quantitative data of CREBBP in the renal tissues of the mice. *P<0.05 vs Sham group; #P<0.05 vs Model group.

Fig.7 QSG-medicated rat serum attenuates uric acid-stimulated exosome secretion from NRK-49F cells. A, B: Western blotting and quantitative data of exosome marker proteins CD63, Hsp70 and TSG101 in each group. *P<0.05 vs Sham group; #P<0.05 vs Model group.

Fig.8 Effect of QSG-medicated rat serum on activation of NRK-49F cells. A, B: Western blotting of protein expression levels of Col-III, α-SMA, FN and E-cad in NRK-49F cells treated with QSG-medicated serum. C, D: Immunofluorescence micrographs showing Col-III and FN expressions in NRK-49F cells treated with QSG-medicated serum. Scale bar=50 µm. *P<0.05 vs Sham group; #P<0.05 vs Model group.

Fig.9 QSG-medicated rat serum decreases miR-330-3p expression and increases CREBBP level to inhibit NRK-49F cell activation. A: miR-330-3p levels in NRK-49F cells treated with QSG-medicated serum. B: CREBBP mRNA levels in NRK-49F cells treated with QSG-medicated serum. C, D: Western blotting of protein expression of CREBBP in NRK-49F cells treated with QSG-medicated serum. *P<0.05 vs Sham group; #P<0.05 vs Model group.

References 25

1	GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2020, 395(10225): 709-33.
2	Wang L, Xu X, Zhang M, et al. Prevalence of chronic kidney disease in China: results from the sixth China chronic disease and risk factor surveillance[J]. JAMA Intern Med, 2023, 183(4): 298-310.
3	Huang RS, Fu P, Ma L. Kidney fibrosis: from mechanisms to therapeutic medicines[J]. Signal Transduct Target Ther, 2023, 8(1): 129.
4	Earle A, Bessonny M, Benito J, et al. Urinary exosomal microRNAs as biomarkers for obesity-associated chronic kidney disease[J]. J Clin Med, 2022, 11(18): 5271.
5	Mahtal N, Lenoir O, Tinel C, et al. MicroRNAs in kidney injury and disease[J]. Nat Rev Nephrol, 2022, 18: 643-62.
6	Zhang YK, Guo CM, Yang SW, et al. NONHSAT021545/miR-330-3p/EREG: a cooperative axis in breast cancer prognosis and treatment[J]. J Clin Med, 2023, 12(7): 2478.
7	Cao YM, Huang WF, Wu F, et al. ZFP36 protects lungs from intestinal I/R-induced injury and fibrosis through the CREBBP/p53/p21/Ba _x pathway[J]. Cell Death Dis, 2021, 12(7): 685.
8	Yang YR, Hu S, Bu FT, et al. Circular RNA CREBBP suppresses hepatic fibrosis via targeting the hsa-miR-1291/LEFTY2 axis[J]. Front Pharmacol, 2021, 12: 741151.
9	Zheng R, Liu H, Gu JX, et al. Upregulated microRNA-330-3p promotes calcification in the bicuspid aortic valve via targeting CREBBP[J]. Mol Med Rep, 2020, 22(3): 2351-63.
10	Wang Y, Zhang L, Jin H, et al. Based on HIF-1α/wnt/β‑catenin pathway to explore the effect of Qingshen Granules on chronic renal failure patients: a randomized controlled trial[J]. Evid Based Complement Alternat Med, 2019, 2019: 7656105.
11	Wang D, Wang YP, Li CP, et al. Effects of Qingshen Granules on immune function in patients with comorbid chronic renal failure and damp-heat syndrome: a multicenter, randomized, controlled trial[J]. Evid Based Complement Alternat Med, 2020, 2020: 5057894.
12	Wang YP, Wang D, Jin H, et al. Effects of Qingshen Granules on Janus Kinase/signal transducer and activator of transcription signaling pathway in rats with unilateral ureteral obstruction[J]. Chung I Tsa Chih Ying Wen Pan, 2018, 38(2): 182-9.
13	Liu M, Jin H, Hu Q, et al. Qingshen Granules-medicated serum reduces transdifferentiation of NRK-52E cells by miR-23b-5p-mediated activation of the Nrf2 pathway[J]. J South Med Univ, 2023, 43(12): 2078-85.
14	Zhou X, Zhao S, Li W, et al. Tubular cell-derived exosomal miR-150-5p contributes to renal fibrosis following unilateral ischemia-reperfusion injury by activating fibroblast in vitro and in vivo . Int J Biol Sci. 2021;17(14):4021-4033.
15	Thongboonkerd V. Roles for exosome in various kidney diseases and disorders[J]. Front Pharmacol, 2019, 10: 1655.
16	Chen SQ, Zhang MJ, Li JM, et al. β-catenin-controlled tubular cell-derived exosomes play a key role in fibroblast activation via the OPN-CD44 axis[J]. J Extracell Vesicles, 2022, 11(3): e12203.
17	Liu X, Liu Z, Wang C, et al. Kidney tubular epithelial cells control interstitial fibroblast fate by releasing TNFAIP8-encapsulated exosomes[J]. Cell Death Dis, 2023, 14(10): 672.
18	Krylova SV, Feng D. The machinery of exosomes: biogenesis, release, and uptake[J]. Int J Mol Sci, 2023, 24(2): 1337.
19	Fan YL, Chen HT, Huang ZX, et al. Emerging role of miRNAs in renal fibrosis[J]. RNA Biol, 2020, 17(1): 1-12.
20	Wei CH, Wu G, Cai Q, et al. Retraction Note to: microRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway[J]. J Hematol Oncol, 2020, 13(1): 142.
21	Wei CH, Zhang RG, Cai Q, et al. MicroRNA-330-3p promotes brain metastasis and epithelial-mesenchymal transition via GRIA3 in non-small cell lung cancer[J]. Aging, 2019, 11(17): 6734-61.
22	Zhang GF, Zhu YL, Jin CZ, et al. CircRNA_0078767 promotes osteosarcoma progression by increasing CDK14 expression through sponging microRNA-330-3p[J]. Chem Biol Interact, 2022, 360: 109903.
23	Ren Y, Li L, Wang MM, et al. Knockdown of circRNA paralemmin 2 ameliorates lipopolysaccharide-induced murine lung epithelial cell injury by sponging miR-330-5p to reduce ROCK2 expression[J]. Immunol Invest, 2022, 51(6): 1707-24.
24	Zhao L, Jiao JX, Yan GH, et al. Circ_0018168 inhibits the proliferation and osteogenic differentiation of fibroblasts in ankylosing spondylitis via regulating miR-330-3p/DKK1 axis[J]. Regen Ther, 2022, 21: 175-84.
25	Jia DS, Augert A, Kim DW, et al. Crebbp loss drives small cell lung cancer and increases sensitivity to HDAC inhibition[J]. Cancer Discov, 2018, 8(11): 1422-37.

[1]	Guangya CHEN, Xingliang XIANG, Zhaoxiang ZENG, Rongzeng HUANG, Shuna JIN, Mingzhong XIAO, Chengwu SONG. Regulatory effect of Diwu Yanggan Decoction on lysoglycerophospholipids in circulating exosomes in a mouse model of nonalcoholic fatty liver disease [J]. Journal of Southern Medical University, 2024, 44(7): 1382-1388.
[2]	Tong YUAN, Yuying GUO, Junling ZHANG, Saijun FAN. Normal mouse serum alleviates radiation pneumonitis in mice by inhibiting the focal adhesion signaling pathway [J]. Journal of Southern Medical University, 2024, 44(5): 801-809.
[3]	SUN Xiaopeng, SHI Hang, ZHANG Lei, LIU Zhong, LI Kewei, QIAN Lingling, ZHU Xingyu, YANG Kangjia, FU Qiang, DING Hua. Exosomes from ectoderm mesenchymal stem cells inhibits lipopolysaccharide-induced microglial M1 polarization and promotes survival of H₂O₂-exposed PC12 cells by suppressing inflammatory response and oxidative stress [J]. Journal of Southern Medical University, 2024, 44(1): 119-128.
[4]	HE Yanjuan, LI Zhuoyi, SHEN Lin, SHI Dinghua, LI Shentang. Cardiac progenitor cells-derived exosomes alleviate myocardial injury by regulating Treg cell differentiation through the mTOR pathway in mice with myocardial infarction [J]. Journal of Southern Medical University, 2023, 43(9): 1644-1650.
[5]	XU Mengqi, SHI Yutong, LIU Junping, WU Minmin, ZHANG Fengmei, HE Zhiqiang, TANG Min. JAG1 affects monocytes-macrophages to reshape the pre-metastatic niche of triple-negative breast cancer through LncRNA MALAT1 in exosomes [J]. Journal of Southern Medical University, 2023, 43(9): 1525-1535.
[6]	LUO Guanfeng, LIU Huaxi, XIE Bei, DENG Yijian, XIE Penghui, ZHAO Xiaoshan, SUN Xiaomin. Therapeutic mechanism of Shenbing Decoction III for renal fibrosis in chronic kidney disease: a study with network pharmacology, molecular docking and validation in rats [J]. Journal of Southern Medical University, 2023, 43(6): 924-934.
[7]	WANG Li, YAN Zhirui, XIA Yaoxiong. Silencing RAB27a inhibits proliferation, invasion and adhesion of triple-negative breast cancer cells [J]. Journal of Southern Medical University, 2023, 43(4): 560-567.
[8]	LIU Yu, ZENG Lian, WANG Weihong, YANG Yanling, WANG Zhou, LIU Jianqi, LI Wei, SUN Jingyu, YU Xiaohong. Human bone marrow mesenchymal stem cell exosome-derived miR-335-5p promotes osteogenic differentiation of human periodontal ligament stem cells to alleviate periodontitis by downregulating DKK1 [J]. Journal of Southern Medical University, 2023, 43(3): 420-427.
[9]	ZHANG Mengying, LI Zhi, PEI Weiya, LI Xueqin, YANG Hui, ZHU Xiaolong, LÜ Kun. M2 macrophage-derived exosomal lncRNA NR_028113.1 promotes macrophage polarization possibly by activating the JAK2/STAT3 signaling pathway [J]. Journal of Southern Medical University, 2023, 43(3): 393-399.
[10]	WU Xiaofeng, ZHAN Riming, CHENG Dazhao, CHEN Li, WANG Tianyu, TANG Xudong. Exosomal FZD10 derived from non-small cell lung cancer cells promotes angiogenesis of human umbilical venous endothelial cells in vitro [J]. Journal of Southern Medical University, 2022, 42(9): 1351-1358.
[11]	GUAN Pengfei, CUI Ruiwen, WANG Qiyou, SUN Yongjian. A 3D hydrogel loaded with exosomes derived from bone marrow stem cells promotes cartilage repair in rats by modulating immunological microenvironment [J]. Journal of Southern Medical University, 2022, 42(4): 528-537.
[12]	DING Kaize, YU Lei, HUANG Zhi, ZHENG Huiling, YANG Xue, TIAN Tian, XIE Rujia. Differential expression profile of miRNAs in amniotic fluid exosomes from fetuses with Down syndrome [J]. Journal of Southern Medical University, 2022, 42(2): 293-299.
[13]	LIU Lei, DU Chengyou, WEI Xufu, LIAO Rui. Correlation of peritumoral circWDR25 expression with the prognosis of patients with hepatocellular carcinoma after curative resection [J]. Journal of Southern Medical University, 2021, 41(9): 1388-1393.
[14]	. Ginsenoside Rh2 inhibits renal fibrosis and renal cell apoptosis in rats with diabetic nephropathy by downregulating discoid domain receptor 1 [J]. Journal of Southern Medical University, 2021, 41(7): 1107-1113.
[15]	. Human umbilical cord mesenchymal stem cell-derived exosomes alleviate pulmonary fibrosis in mice by inhibiting epithelial-mesenchymal transition [J]. Journal of Southern Medical University, 2020, 40(07): 988-994.